Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by Jiro Fujita and Hideta Nakamura.
Jiro Fujita
Connection Strength
4.994
Hideta Nakamura
  1. Case Report: Iliopsoas Hematoma during the Clinical Course of Severe COVID-19 in Two Male Patients. Am J Trop Med Hyg. 2021 Jan 13; 104(3):1018-1021.
    View in: PubMed
    Score: 0.924
  2. Use of the interleukin 6 inhibitor tocilizumab in Japanese patients with cytokine release syndrome caused by COVID-19-related acute respiratory distress syndrome: A case series. Respir Investig. 2020 11; 58(6):510-512.
    View in: PubMed
    Score: 0.907
  3. Acute Hypertriglyceridaemia Caused by Tocilizumab in a Patient with Severe COVID-19. Intern Med. 2020 Nov 15; 59(22):2945-2949.
    View in: PubMed
    Score: 0.904
  4. Serum levels of receptor-interacting protein kinase-3 in patients with COVID-19. Crit Care. 2020 08 04; 24(1):484.
    View in: PubMed
    Score: 0.896
  5. Serum KL-6 can distinguish between different phenotypes of severe COVID-19. J Med Virol. 2021 01; 93(1):158-160.
    View in: PubMed
    Score: 0.893
  6. Subpleural Curvilinear Shadows Associated with COVID-19. Intern Med. 2021 Aug 01; 60(15):2505-2506.
    View in: PubMed
    Score: 0.237
  7. Case Report: Ischemic Enterocolitis Associated with Coronavirus Disease 2019: Two Case Reports and a Review of the Literature. Am J Trop Med Hyg. 2021 Mar 18; 104(5):1655-1658.
    View in: PubMed
    Score: 0.234
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.